Introduction The aim of this study is to conduct a meta-analysis to assess the efficacy of
yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer …

Simple Summary Cholangiocarcinoma is a rare cancer with a dismal prognosis. The rate of
recurrence after treatment of localized disease is high. In this review, we discuss the …

Purpose To determine the safety and effectiveness of yttrium-90 transarterial
radioembolization (TARE) combined with systemic gemcitabine, cisplatin, and capecitabine …

Radiation segmentectomy with a dose of> 190 Gy using yttrium-90 (90 Y) glass
microspheres for intrahepatic cholangiocarcinoma (iCCA) has been shown to be safe and …

Background Intrahepatic cholangiocarcinoma (iCCA) is a rare biliary tract cancer with
increasing incidence and poor survival rates. This study aims to evaluate the incidence and …

We have previously shown that ablative radiotherapy (A-RT) with a biologically effective
dose (BED10)≥ 80.5 Gy for patients with unresectable intrahepatic cholangiocarcinoma …

Purpose Transarterial radioembolization (TARE) with Yttrium-90 resin microspheres is a
treatment option for patients with intrahepatic cholangiocarcinoma (ICC). However …

Objectives To evaluate safety and effectiveness of selective internal radiation therapy (SIRT)
using yttrium-90 for localized and locally advanced intrahepatic cholangiocarcinoma (iCCA) …

Background: Intrahepatic cholangiocarcinoma (ICC), a malignancy originating from the
epithelial cells of bile ducts, has shown a notable rise in its incidence over the years. It ranks …

Background: Endoscopic radiofrequency ablation (RFA) is used for the treatment of
unresectable malignant biliary obstruction (MBO). The postoperative adverse events …